Astrazeneca Pharma India share price
You have to be logged in to add this to Watchlist.Astrazeneca Pharma India is trading 1.87% upper at Rs 6,455.40 as compared to its last closing price. Astrazeneca Pharma India has been trading in the price range of 6,486.75 & 6,313.55. Astrazeneca Pharma India has given 14.35% in this year & -11.35% in the last 5 days.
Astrazeneca Pharma India has TTM P/E ratio 243.26 as compared to the sector P/E of 33.29.
The company posted a net profit of 38.43 Crores in its last quarter.
Listed peers of Astrazeneca Pharma India include Pfizer (0.36%), Neuland Laboratories (-0.21%), Astrazeneca Pharma India (1.87%) etc.
Astrazeneca Pharma India has a 25.00% public holding.The Mutual Fund holding in Astrazeneca Pharma India was at 5.05% in 30 Sep 2024. The MF holding has increased from the last quarter. The FII holding in Astrazeneca Pharma India was at 2.90% in 30 Sep 2024. The FII holding has increased from the last quarter.
Astrazeneca Pharma India share price range
|
| ||||
|
| ||||
Astrazeneca Pharma India share Key Metrics
| Market Cap ( ₹ Cr.) | 15,799.63 | ||||||||||||||||||
|
|
Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Astrazeneca Pharma India Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
| 13-Nov-24 | Quarterly Results |
| 08-Aug-24 | Quarterly Results |
| 27-May-24 | Audited Results & Dividend |
| 08-Feb-24 | Quarterly Results |
| 09-Nov-23 | Quarterly Results |
| 14-Aug-23 | Quarterly Results |
| 30-May-23 | Audited Results & Dividend |
| 10-Feb-23 | Quarterly Results |
| 11-Nov-22 | Quarterly Results |
| 08-Aug-22 | Quarterly Results |
| Meeting Date | Announcement On | Purpose |
| 08-Aug-24 | 16-Jul-24 | AGM |
| 07-Apr-24 | 06-Mar-24 | POM |
| 08-Feb-24 | 05-Jan-24 | POM |
| 14-Aug-23 | 30-May-23 | AGM |
| 27-Feb-23 | 25-Jan-23 | POM |
| 08-Aug-22 | 26-May-22 | AGM |
| 31-Mar-22 | 23-Feb-22 | POM |
| 09-Aug-21 | 26-May-21 | AGM |
| Announcement On | Record Date | Ex-Dividend | Dividend Value |
| 27-May-24 | 05-Jul-24 | 05-Jul-24 | 24 |
| 30-May-23 | 14-Jul-23 | 14-Jul-23 | 16 |
| 26-May-22 | 08-Jul-22 | 07-Jul-22 | 8 |
| 09-Aug-21 | 20-Aug-21 | 18-Aug-21 | 2 |
FAQs about Astrazeneca Pharma India share price
Astrazeneca Pharma India is trading at 6455.40 as on Mon Nov 25 2024 10:28:52. This is 1.87% upper as compared to its previous closing price of 6336.90.
The market capitalization of Astrazeneca Pharma India is 15799.63 Cr as on Mon Nov 25 2024 10:28:52.
The 52 wk high for Astrazeneca Pharma India is 8139.85 whereas the 52 wk low is 4050.15
Astrazeneca Pharma India can be analyzed on the following key metrics -
- TTM P/E: 243.26
- Sector P/E: 33.29
- Dividend Yield: 0.38%
- D/E ratio: 0.03
Astrazeneca Pharma India reported a net profit of 161.51 Cr in 2024.
Astrazeneca Pharma India Quick Links
Astrazeneca Pharma India Dividend Astrazeneca Pharma India Bonus Astrazeneca Pharma India News Astrazeneca Pharma India AGM Astrazeneca Pharma India Rights Astrazeneca Pharma India Splits Astrazeneca Pharma India Board Meetings Astrazeneca Pharma India Key Metrics Astrazeneca Pharma India Shareholdings Astrazeneca Pharma India Profit Loss Astrazeneca Pharma India Balance Sheet Astrazeneca Pharma India Cashflow Astrazeneca Pharma India Q1 Results Astrazeneca Pharma India Q2 Results Astrazeneca Pharma India Q3 Results Astrazeneca Pharma India Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks